Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -936 | -42,694 | -29,717 | -19,231 | -9,822 |
| Depreciation Amortization | 67 | 229 | 161 | 137 | 80 |
| Accounts receivable | -11,500 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 525 | -838 | -1,006 | 112 | -82 |
| Other Working Capital | -11,698 | 1,635 | 1,495 | 137 | 866 |
| Other Operating Activity | 12,757 | 11,461 | 4,959 | 2,345 | 1,052 |
| Operating Cash Flow | $-10,785 | $-30,207 | $-24,108 | $-16,500 | $-7,906 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 20,500 | 69,849 | 57,749 | 44,355 | 24,355 |
| PPE Investments | -380 | -1,691 | -926 | -815 | -699 |
| Purchase Of Investment | -9,285 | -71,738 | -59,545 | -22,136 | -5,382 |
| Investing Cash Flow | $10,835 | $-3,580 | $-2,722 | $21,404 | $18,274 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,975 | 34,460 | 34,460 | 34,460 | 34,460 |
| Common Stock Issued | 28,390 | 453 | 7 | 7 | 7 |
| Other Financing Activity | 0 | 319 | 320 | 320 | 410 |
| Financing Cash Flow | $33,365 | $35,232 | $34,787 | $34,787 | $34,877 |
| Beginning Cash Position | 10,686 | 9,241 | 9,241 | 9,241 | 9,241 |
| End Cash Position | 44,101 | 10,686 | 17,198 | 48,932 | 54,486 |
| Net Cash Flow | $33,415 | $1,445 | $7,957 | $39,691 | $45,245 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,785 | -30,207 | -24,108 | -16,500 | -7,906 |
| Capital Expenditure | -380 | -1,691 | -926 | -815 | -699 |
| Free Cash Flow | -11,165 | -31,898 | -25,034 | -17,315 | -8,605 |